更年期障害の世界市場レポート 2024

更年期障害の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には6.3%の年間複合成長率（CAGR）で226億4,000万米ドルに成長すると予想されます。予測期間の成長は、認知的健康への注目の高まり、職場での健康プログラムの実施、メンタルヘルスサービスの統合、継続的な教育と啓発キャンペーン、個別化医療の進歩によるものと考えられます。予測期間の主な動向には、更年期障害のデジタルヘルスソリューションの開発、非ホルモン療法の探求、長期的な健康転帰に関する調査、遠隔医療とバーチャルヘルスの普及、治療アプローチにおける継続的な技術革新が含まれます。

女性の運動不足傾向の拡大により、近い将来、更年期障害市場の成長が促進されると予想されます。身体的不活動とは、余暇の移動、交通機関、職業上の移動などの身体活動が最小限またはまったく行われていないことを指します。更年期の女性の間で運動不足が懸念されるように増加していることは、更年期症状の管理、関連する健康リスクへの対処、全体的な幸福度の向上を目的とした製品やサービスの需要の増加に寄与しています。 2023年9月に疾病管理予防センターが報告したデータによると、身体活動をしていないと報告した女性の割合は7.9%急増し、2020年の21万3,555人から2021年には23万493人に増加しました。その結果、女性の間で身体活動不足が増加する傾向は、 更年期障害市場の成長を支える重要な原動力です。

ライフスタイルの変化の急増により、今後数年間で更年期障害市場の拡大が促進されると予想されます。ライフスタイルの変化には、個人の選択や行動の変化が伴い、健康や全体的な幸福に影響を与えます。 更年期障害の自然な生物学的段階では、ライフスタイルを調整することで更年期症状を効果的に管理し、一般的な健康状態を促進できます。 更年期障害中のライフスタイルの修正には、健康的な食事、定期的な運動、十分な睡眠、喫煙や過度のアルコール摂取の回避、リラックスできる活動への参加などが含まれます。たとえば、2021年 1月に政府デジタルサービスが報告したように、英国の成人 5,000人以上を対象とした大規模な世論調査では、18歳以上の個人の80%がライフスタイルの選択を変更するつもりであることが明らかになりました。したがって、ライフスタイル変更のエスカレートする傾向は、更年期障害市場の成長の原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の更年期障害市場、治療別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 栄養補助食品
• 店頭（OTC）医薬品
• 世界の更年期障害市場、投与経路別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 外用
• 経口
• 注射
• 世界の更年期障害市場、流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院
• 小売り
• オンライン薬局
• 世界の更年期障害市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院
• 診断センター
• 専門クリニック
• その他のエンドユーザー

第7章 地域および国の分析

• 世界の閉経市場、地域別、実績および予測、2018年から2023年、2023年から2028年、2033年
• 世界の閉経市場、国別、実績および予測、2018年から2023年、2023年から2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 更年期障害市場の競合情勢
• 更年期障害市場の企業プロファイル
  • Pfizer Inc.
  • Johnson &Johnson Inc
  • The Procter &Gamble Company
  • F. Hoffmann-La Roche AG
  • Merck &Co. Inc.

第31章 その他の大手および革新的な企業

• AbbVie Inc.
• Bayer AG
• Novartis AG
• Sanofi SA
• Abbott Laboratories Ltd.
• GSK plc
• Eli Lilly and Company
• Amgen Inc.
• Novo Nordisk A/S
• Viatris Inc.
• Teva Pharmaceutical Industries Ltd.
• Astellas Pharma Inc.
• Sun Pharmaceutical Industries Limited
• Cipla Inc.
• Dr. Reddy's Laboratories Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Menopause is a natural biological process signifying the cessation of a woman's menstrual cycles and reproductive years, officially diagnosed when there is a 12-month absence of a menstrual period. This phase is characterized by various physical and hormonal changes, denoting the conclusion of reproductive capabilities as the ovaries cease egg release, and the hormones progesterone and estrogen decline.

The primary treatments for menopause involve dietary supplements and over-the-counter (OTC) pharmaceutical products. Dietary supplements, distinct from regular food, serve to complement the diet. These treatments are administered topically, orally, or through injectables, and are distributed through channels such as hospitals, retail outlets, and online pharmacies. They cater to end users such as hospitals, diagnostic centers, specialty clinics, and others.

The menopause market research report is one of a series of new reports from The Business Research Company that provides menopause market statistics, including menopause industry global market size, regional shares, competitors with a menopause market share, detailed menopause market segments, market trends and opportunities, and any further data you may need to thrive in the menopause industry. This menopause market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The menopause market size has grown strongly in recent years. It will grow from $16.53 billion in 2023 to $17.74 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historical period can be attributed to factors such as the rising average life expectancy, increased awareness of women's health, the popularity of nutritional supplements, improvements in healthcare access, heightened focus on stress and lifestyle management, and the influence of patient advocacy efforts.

The menopause market size is expected to see strong growth in the next few years. It will grow to $22.64 billion in 2028 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to an increased focus on cognitive health, the implementation of wellness programs in the workplace, the integration of mental health services, ongoing education and awareness campaigns, and the advancement of personalized medicine. Major trends in the forecast period include the development of digital health solutions for menopause, the exploration of non-hormonal therapies, research on long-term health outcomes, the widespread adoption of telemedicine and virtual health, and ongoing technological innovations in treatment approaches.

The escalating trend of physical inactivity among women is anticipated to drive the growth of the menopause market in the foreseeable future. Physical inactivity refers to minimal or absent engagement in physical activities encompassing leisure-time mobility, transportation, or occupational movement. The concerning rise in physical inactivity among menopausal women contributes to an increased demand for products and services aimed at managing menopausal symptoms, addressing associated health risks, and enhancing overall well-being. As per data reported by the Centers for Disease Control and Prevention in September 2023, the percentage of women reporting no physical activity surged by 7.9%, increasing from 213,555 in 2020 to 230,493 in 2021. Consequently, this trend of rising physical inactivity among women is a significant driver behind the growth of the menopause market.

The surge in lifestyle modifications is anticipated to propel the expansion of the menopause market in the coming years. Lifestyle changes involve shifts in individuals' choices and behaviors that impact their health and overall well-being. During the natural biological phase of menopause, making lifestyle adjustments can effectively manage menopausal symptoms and promote general health. Lifestyle modifications during menopause encompass adopting a healthy diet, regular exercise, adequate sleep, avoiding smoking and excessive alcohol consumption, and engaging in relaxing activities. For example, as reported by the Government Digital Service in January 2021, an extensive poll involving over 5,000 adults in England revealed that 80% of individuals aged 18 and above intended to modify their lifestyle choices. Hence, the escalating trend of lifestyle modifications stands as a driving force behind the growth of the menopause market.

The absence of adequate understanding poses a significant barrier to the development of targeted and effective treatments for menopausal symptoms. Women grappling with these symptoms often experience a notably diminished health-related quality of life (HRQoL) and heightened work impairment. The lack of comprehension and support can deter women from taking essential steps to manage these risks and sustain their overall well-being. For instance, research reported by the National Library of Medicine in June 2022 highlighted that 67% of women had insufficient awareness about menopause. Additionally, a survey conducted among 220 women in the UK unveiled a concerning lack of formal menopausal education. Consequently, this lack of understanding stands as a constraint hampering the growth potential of the menopause market.

Prominent companies operating in the menopause market are concentrating on the development of innovative products, exemplified by the introduction of Your Meno Ease Capsules, aiming to better cater to the needs of existing consumers. Your Meno Ease Capsules represent a dietary supplement designed to alleviate menopausal symptoms among women. This supplement comprises a blend of vitamins, minerals, and various nutrients considered beneficial for women experiencing menopause. PharmaLinea Ltd., a Slovenia-based manufacturer specializing in menopausal dietary supplements, introduced Your Meno Ease Capsules in October 2022. This innovative product stands out due to its unique composition and clinically validated functionalities, targeting general alleviation of menopausal symptoms while offering additional benefits for mood, mental acuity, distress management, cardiovascular health, and bone wellness. The capsule contains 75 mg of Qratol, a resveratrol compound with multiple health advantages, along with 40 mg of Qsoy, a soy derivative known for its efficacy in reducing menopausal symptoms, complemented by 1.6 mg of vitamin B6.

In March 2022, Amyris, Inc., a US-based entity specializing in the production and advancement of menopausal pharmaceuticals, acquired MenoLabs LLC in a transaction whose financial details were undisclosed. This strategic acquisition is anticipated to expedite the company's growth trajectory and solidify a prominent standing within the menopausal sector. The incorporation of MenoLabs LLC into Amyris Inc.'s operational framework is expected to leverage the latter's scientific approach in addressing routine health and wellness concerns. MenoLabs LLC, a US-based health and technology enterprise, specializes in the development of treatments targeting menopause-related issues.

Major companies operating in the menopause market report are Pfizer Inc., Johnson & Johnson Inc, The Procter & Gamble Company, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, Abbott Laboratories Ltd., GSK plc, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Sun Pharmaceutical Industries Limited, Cipla Inc., Dr. Reddy's Laboratories Ltd., Apotex Inc., Rainbow Light Nutritional Systems LLC, Mithra Pharmaceuticals SA, TherapeuticsMD Inc., Theramex SpA, Pure Encapsulations LLC., Mylan N.V., PADAGIS LLC, Serenity Pharmaceuticals LLC, ASCEND Therapeutics US LLC

North America was the largest region in the menopause market in 2023. The regions covered in the menopause market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the menopause market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The menopause market includes revenues earned by entities by providing hormone replacement therapies, selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Menopause Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on menopause market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for menopause? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The menopause market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Treatment: Dietary Supplements; Over-The-Counter (OTC) Pharma Products
• 2) By Route of Administration: Topical; Oral; Injectables
• 3) By Distribution Channel: Hospital; Retail; Online Pharmacies
• 4) By End User: Hospital; Diagnostic Centers; Specialty Clinics; Other End Users
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Inc; The Procter & Gamble Company; F. Hoffmann-La Roche AG; Merck & Co. Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Menopause Market Characteristics

3. Menopause Market Trends And Strategies

4. Menopause Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Menopause Market Size and Growth

• 5.1. Global Menopause Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Menopause Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Menopause Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Menopause Market Segmentation

• 6.1. Global Menopause Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Dietary Supplements
• Over-The-Counter (OTC) Pharma Products
• 6.2. Global Menopause Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Topical
• Oral
• Injectables
• 6.3. Global Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospital
• Retail
• Online Pharmacies
• 6.4. Global Menopause Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospital
• Diagnostic Centers
• Specialty Clinics
• Other End Users

7. Menopause Market Regional And Country Analysis

• 7.1. Global Menopause Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Menopause Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Menopause Market

• 8.1. Asia-Pacific Menopause Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Menopause Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Menopause Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Menopause Market

• 9.1. China Menopause Market Overview
• 9.2. China Menopause Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Menopause Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Menopause Market

• 10.1. India Menopause Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Menopause Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Menopause Market

• 11.1. Japan Menopause Market Overview
• 11.2. Japan Menopause Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Menopause Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Menopause Market

• 12.1. Australia Menopause Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Menopause Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Menopause Market

• 13.1. Indonesia Menopause Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Menopause Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Menopause Market

• 14.1. South Korea Menopause Market Overview
• 14.2. South Korea Menopause Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Menopause Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Menopause Market

• 15.1. Western Europe Menopause Market Overview
• 15.2. Western Europe Menopause Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Menopause Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Menopause Market

• 16.1. UK Menopause Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Menopause Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Menopause Market

• 17.1. Germany Menopause Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Menopause Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Menopause Market

• 18.5. France Menopause Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.6. France Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.7. France Menopause Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Menopause Market

• 19.9. Italy Menopause Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.10. Italy Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.11. Italy Menopause Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Menopause Market

• 20.13. Spain Menopause Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.14. Spain Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.15. Spain Menopause Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Menopause Market

• 21.1. Eastern Europe Menopause Market Overview
• 21.2. Eastern Europe Menopause Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Menopause Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Menopause Market

• 22.1. Russia Menopause Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Menopause Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Menopause Market

• 23.1. North America Menopause Market Overview
• 23.2. North America Menopause Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Menopause Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Menopause Market

• 24.1. USA Menopause Market Overview
• 24.2. USA Menopause Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Menopause Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Menopause Market

• 25.1. Canada Menopause Market Overview
• 25.2. Canada Menopause Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Menopause Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Menopause Market

• 26.1. South America Menopause Market Overview
• 26.2. South America Menopause Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Menopause Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Menopause Market

• 27.1. Brazil Menopause Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Menopause Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Menopause Market

• 28.1. Middle East Menopause Market Overview
• 28.2. Middle East Menopause Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Menopause Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Menopause Market

• 29.1. Africa Menopause Market Overview
• 29.2. Africa Menopause Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Menopause Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Menopause Market Competitive Landscape And Company Profiles

• 30.1. Menopause Market Competitive Landscape
• 30.2. Menopause Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Johnson & Johnson Inc
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. The Procter & Gamble Company
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. F. Hoffmann-La Roche AG
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Merck & Co. Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Menopause Market Other Major And Innovative Companies

• 31.1. AbbVie Inc.
• 31.2. Bayer AG
• 31.3. Novartis AG
• 31.4. Sanofi S.A
• 31.5. Abbott Laboratories Ltd.
• 31.6. GSK plc
• 31.7. Eli Lilly and Company
• 31.8. Amgen Inc.
• 31.9. Novo Nordisk A/S
• 31.10. Viatris Inc.
• 31.11. Teva Pharmaceutical Industries Ltd.
• 31.12. Astellas Pharma Inc.
• 31.13. Sun Pharmaceutical Industries Limited
• 31.14. Cipla Inc.
• 31.15. Dr. Reddy's Laboratories Ltd.

32. Global Menopause Market Competitive Benchmarking

33. Global Menopause Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Menopause Market

35. Menopause Market Future Outlook and Potential Analysis

• 35.1 Menopause Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Menopause Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Menopause Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer